Centre for Medicine Use and Safety

Establishing healthcare standards of tomorrow

About us

Our ultimate goal is to optimise the safe and effective use of medicine through multidisciplinary research.

Research groups

Our research groups are led by world-leading researchers.

Translation and research capabilities and tools

Find out about our research and translational capabilities and tools.

Major projects, trials and guidelines

Learn more about our current major projects, clinical trials and guidelines.

PhD program

Our PhD program attracts the best and brightest.

Find a researcher

Build a collaboration.

Latest news from CMUS

Monash University calls for public input on first dementia guidelines update in a decade

Monash University is calling on healthcare professionals and the broader community to help shape the future of dementia care, opening public consultation on the first major draft update to the national clinical guidelines.

Monash research shows how to close the maternal health gap

MIPS researchers have unlocked the blueprint of how Australia’s health system can make better use of antenatal lifestyle coaching to improve patient outcomes and dismantle entrenched health inequality.

Dr Amanda Cross

Monash researchers launch ‘OZ-ABCD’ tool to curb medication harm in aged care

A multidisciplinary team of healthcare professionals and medication safety experts have developed the first national consensus list of medicines with a high risk of harm in Australian residential aged care.

Amanda and Simon

New microlearning video series to support the safer use of psychotropic medications in residential aged care

Researchers have launched a series of microlearning education videos to support safer, more appropriate use of psychotropic medications for people living with dementia and in residential aged care.

Professor Simon Bell and Dr Alene Yong

Monash University publishes a world first clinical practice guideline for the appropriate use of psychedelics

A new Australian Clinical Practice Guideline for the Appropriate Use of MDMA-AP for PTSD has been approved by the National Health and Medical Research Council (NHMRC).

Johnson G

New project to investigate the enhanced management of chronic respiratory conditions in primary care

A new three phase project to enhance how patients are treated for chronic respiratory conditions in primary care will go ahead thanks to a $2 million MRFF grant.

Carl Kirkpatrick

Professor Carl Kirkpatrick named 2025 ASCEPT Fellow

Professor Carl Kirkpatrick has been named as a 2025 Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Fellow.

New resource to support the improvement of medication management

Researchers at Monash University and Flinders University have released a new guide on how to establish and lead a quality improvement collaborative (QIC).

Dr Amanda Cross

Monash University researcher appointed to the board of the Asthma Council

The National Asthma Council Australia (NAC) has announced the appointment of Pharmaceutical Society of Australia (PSA) nominee Dr Amanda Cross to the board.

Other research themes